Our monthly podcast brings you big-picture insights from leading investment experts, exploring the opportunities, challenges and risks shaping investor portfolios.
This month's guest is Ailsa Craig, manager of the International Biotechnology Trust (IBT), who has extensive experience in the biotech industry.
In this month’s episode, we discuss a range of topics including the investment case for biotech, the role of M&A in plugging big pharma’s patent cliff and the most exciting developments in the sector.
00:00 Introduction
00:36 Background to asset management
02:58 What is biotech?
04:30 Most exciting developments in treatments
05:47 The merit of an active strategy
07:45 How has Trump affected M&A
10:04 Size of acquisitions
11:31 Credible challengers outside the US
12:36 Outlook for GLP1s
15:13 Impact of AI in biotech
16:21 Has sector consolidation been a positive?
18:01 Thoughts on current sector recovery
19:19 Thoughts on current market outlook
21:43 Risk warning
Please note that this podcast was recorded on 19 August 2025.
